GoAI
Get started
STERIS plc logo

STERIS plc

STE

NYSEHealthcareMedical - Specialties

Open in GoAI

Previous close

$237.93

+$2.19 · +0.93%

Aug 21, 4:00 PM ET

STE company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

92

Deep Value

Momentum

41

Neutral

Sentiment

63

Bullish

Risk resilience

70

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

Industry
Medical - Specialties
Sector
Healthcare
Headquarters
US
CEO
Daniel A. Carestio
Listed since
Jun 1, 1992
Employees
17,937

Market position

Day range

Current $237.93

52-week range

Current $237.93

Open
$236.42
Previous close
$235.74
Volume
307.81K
0.39× average
Average volume
791.64K
Average daily volume
Market cap
23.19B USD
Beta
0.91
Market reference 1
50-day average
$219.9
+8.20% above average
200-day average
$234.19
+1.60% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
23.36B USD
P/E (TTM)
29.02×
P/B (TTM)
3.22×
P/S (TTM)
3.84×
EV / EBITDA
14.65×
Earnings yield
3.62%
Free cash flow yield
4.48%
Dividend yield
1.06%

Profitability & efficiency

Gross margin
44.43%
Operating margin
18.91%
Net margin
13.33%
Return on equity
10.93%
Return on assets
7.31%
Return on invested capital
8.47%

Financial health

Debt / equity
0.28×
Current ratio
2.09×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends49%32%15%-2%Gross margin, FY2022: 44.59%Gross margin, FY2023: 43.66%Gross margin, FY2024: 43.17%Gross margin, FY2025: 44.01%Gross margin, FY2026: 44.25%Operating margin, FY2022: 11.31%Operating margin, FY2023: 17.44%Operating margin, FY2024: 16.27%Operating margin, FY2025: 15.87%Operating margin, FY2026: 18.56%Net margin, FY2022: 5.77%Net margin, FY2023: 2.36%Net margin, FY2024: 7.36%Net margin, FY2025: 11.26%Net margin, FY2026: 13.23%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 44.59%. Gross margin FY2023 43.66%. Gross margin FY2024 43.17%. Gross margin FY2025 44.01%. Gross margin FY2026 44.25%. Operating margin FY2022 11.31%. Operating margin FY2023 17.44%. Operating margin FY2024 16.27%. Operating margin FY2025 15.87%. Operating margin FY2026 18.56%. Net margin FY2022 5.77%. Net margin FY2023 2.36%. Net margin FY2024 7.36%. Net margin FY2025 11.26%. Net margin FY2026 13.23%.

Income trends

Revenue

5.94B USD+8.73%

Operating income

1.1B USD+27.13%

Net income

785.1M USD+27.73%
Income trends across reported periods6.52B USD4.19B USD1.86B USD−475.86M USDRevenue, FY2022: 4.22B USDRevenue, FY2023: 4.54B USDRevenue, FY2024: 5.14B USDRevenue, FY2025: 5.46B USDRevenue, FY2026: 5.94B USDOperating income, FY2022: 477.82M USDOperating income, FY2023: 791.1M USDOperating income, FY2024: 836.12M USDOperating income, FY2025: 866.64M USDOperating income, FY2026: 1.1B USDNet income, FY2022: 243.89M USDNet income, FY2023: 107.03M USDNet income, FY2024: 378.24M USDNet income, FY2025: 614.64M USDNet income, FY2026: 785.1M USDFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 4.22B USD. Revenue FY2023 4.54B USD. Revenue FY2024 5.14B USD. Revenue FY2025 5.46B USD. Revenue FY2026 5.94B USD. Operating income FY2022 477.82M USD. Operating income FY2023 791.1M USD. Operating income FY2024 836.12M USD. Operating income FY2025 866.64M USD. Operating income FY2026 1.1B USD. Net income FY2022 243.89M USD. Net income FY2023 107.03M USD. Net income FY2024 378.24M USD. Net income FY2025 614.64M USD. Net income FY2026 785.1M USD.
Metric (USD)FY2026FY2025FY2024FY2023FY2022
Revenue5.94B USD5.46B USD5.14B USD4.54B USD4.22B USD
Cost of goods sold3.31B USD3.06B USD2.92B USD2.56B USD2.34B USD
Gross profit2.63B USD2.4B USD2.22B USD1.98B USD1.88B USD
Research and development112.9M USD107.65M USD103.68M USD98.48M USD86.66M USD
Selling, general, and administrative1.41B USD1.33B USD1.25B USD1.09B USD1.32B USD
Operating expenses1.52B USD1.54B USD1.38B USD1.19B USD1.41B USD
Interest income9.8M USD8.4M USD11.04M USD—6.28M USD
Interest expense60.7M USD86.26M USD144.35M USD110.84M USD89.49M USD
Depreciation and amortization486.5M USD476.22M USD565.24M USD422.53M USD553.1M USD
Operating income1.1B USD866.64M USD836.12M USD791.1M USD477.82M USD
Net income785.1M USD614.64M USD378.24M USD107.03M USD243.89M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$271.33

14.04% upside
Past 12 months12-month forecastHigh $275Average $271.33Low $269

Rating distribution

14 ratings
Strong buy00%
Buy1286%
Hold214%
Sell00%
Strong sell00%

STE peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding STE

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
713.55M
Weight
0.03%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard S&P 500 ETF logoVanguard S&P 500 ETFVOO
Market value
588.22M
Weight
0.03%
AUM
1.7T USD
Expense ratio
0.03%
Price / 1D
$703.71+0.39%
Vanguard Morningstar Mid-Cap ETF logoVanguard Morningstar Mid-Cap ETFVO
Market value
484.79M
Weight
0.21%
AUM
224.7B USD
Expense ratio
0.03%
Price / 1D
$82.97+0.53%
iShares Core S&P 500 ETF logoiShares Core S&P 500 ETFIVV
Market value
311.63M
Weight
0.04%
AUM
891.84B USD
Expense ratio
0.03%
Price / 1D
$769.31+0.39%
State Street SPDR S&P 500 ETF logoState Street SPDR S&P 500 ETFSPY
Market value
287.58M
Weight
0.04%
AUM
817.87B USD
Expense ratio
0.09%
Price / 1D
$765.72+0.41%
Vanguard Morningstar Value ETF logoVanguard Morningstar Value ETFVTV
Market value
213.37M
Weight
0.08%
AUM
256.5B USD
Expense ratio
0.03%
Price / 1D
$226.4+0.54%
Invesco S&P 500 Equal Weight ETF logoInvesco S&P 500 Equal Weight ETFRSP
Market value
211.59M
Weight
0.21%
AUM
100.27B USD
Expense ratio
0.20%
Price / 1D
$221.67+0.63%
State Street Health Care Select Sector SPDR ETF logoState Street Health Care Select Sector SPDR ETFXLV
Market value
166.31M
Weight
0.37%
AUM
44.76B USD
Expense ratio
0.08%
Price / 1D
$174.62+1.29%

Continue in GoAI

Research STE

research.disclaimer